SEC Form 4 research
| Issuer | Roivant Sciences Ltd. |
|---|---|
| Tickers | ROIV |
| Reporting owners | 44 |
| Officers and directors | 13 |
| Last public filing | 2026-11-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-05 | 2026-11-03 | Venker Eric | S | 200,000 | $36.31 | Not reported |
| 2026-10-30 | 2026-10-28 | Venker Eric | S | 200,000 | $36.59 | Not reported |
| 2026-10-27 | 2026-10-23 | Oren Ilan | A | 810 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | Epperly Melissa B, | A | 513 | $0 | Not reported |
| 2026-10-27 | 2026-10-23 | MOMTAZEE JAMES C | A | 383 | $0 | Not reported |
| 2026-10-22 | 2026-10-20 | Venker Eric | S | 14,144 | $35.42 | Not reported |
| 2026-10-22 | 2026-10-20 | Venker Eric | S | 185,856 | $35.09 | Not reported |
| 2026-10-05 | 2026-10-01 | Epperly Melissa B, | S | 900 | $36.57 | Not reported |
| 2026-10-05 | 2026-10-01 | Epperly Melissa B, | S | 16,850 | $36.08 | Not reported |
| 2026-10-02 | 2026-09-30 | Venker Eric | S | 200,000 | $36.62 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.